(Q47695857)

4 February 2018

title

Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia (English)

1 reference

4 February 2018

1 reference

1 reference

Huayuan Zhu

1

1 reference

4 February 2018

Wei Wu

2

1 reference

4 February 2018

Yuan Fu

3

1 reference

4 February 2018

Wenyi Shen

4

1 reference

4 February 2018

Kourong Miao

5

1 reference

4 February 2018

Min Hong

6

1 reference

4 February 2018

Wei Xu

7

1 reference

4 February 2018

Ken H Young

8

1 reference

4 February 2018

Peng Liu

9

1 reference

4 February 2018

Jianyong Li

10

1 reference

4 February 2018

publication date

25 August 2013

1 reference

4 February 2018

published in

Annals of Hematology

1 reference

4 February 2018

volume

93

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

425-435

1 reference

4 February 2018

Chronic lymphocytic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Prognostic factors in chronic lymphocytic leukemia-what do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

What's in the 'BAG'?--A functional domain analysis of the BAG-family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Molecular chaperone targeting and regulation by BAG family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 protein delocalisation in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 regulates motility and adhesion of epithelial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Transcriptional upregulation of BAG3 upon proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Altered gene expression in busulfan-resistant human myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

The role of Bcl-2 family proteins in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Identification of a Btk-BAG3 complex induced by oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1883-1

10.1007/S00277-013-1883-1

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018